John Massie
John Massie
Cardiovascular disease risk screening in Australia: evidence and data gaps [0.03%]
澳大利亚心血管疾病风险筛查：证据和数据差距
Ellie Paige,Natalie Raffoul,Emma Lonsdale et al.
Ellie Paige et al.
Eleanor J Beck,Lauren Ball,Breanna M Lepre et al.
Eleanor J Beck et al.
Designing digital health applications for climate change mitigation and adaptation [0.03%]
设计数字健康应用程序以应对气候变化的缓解和适应
Zerina Lokmic-Tomkins,Ann Borda,Kimberly Humphrey
Zerina Lokmic-Tomkins
Gender diversity of clinical practice guideline panels in Australia: important opportunities for progress [0.03%]
澳大利亚临床实践指南小组的性别多样性：重要的进步机遇
Cheryl Carcel,Mark Woodward
Cheryl Carcel
Mark J Ferson,Reannon Johnson,Toni Cains
Mark J Ferson
Takeaway tinctures [0.03%]
外带药剂
Michael Tran,Katrina Anderson
Michael Tran
The representation of women on Australian clinical practice guideline panels, 2010-2020 [0.03%]
2010-2020年澳大利亚临床实践指南小组中女性形象的展现
Anna Shalit,Lauren Vallely,Renae Nguyen et al.
Anna Shalit et al.
Objectives: To assess the composition by gender of Australian clinical practice guideline development panels; to explore guideline development-related factors that influence the composition of panels. ...
Alexander Larcombe
Alexander Larcombe
The cost-effectiveness of universal hepatitis B screening for reaching WHO diagnosis targets in Australia by 2030 [0.03%]
实现澳大利亚2030年WHO诊断目标的乙肝病毒筛查的成本效益分析
Yinzong Xiao,Margaret E Hellard,Alexander J Thompson et al.
Yinzong Xiao et al.
Objectives: To assess the impact on diagnosis targets, cost, and cost-effectiveness of universal hepatitis B screening in Australia. Design: ...